397 Preoperative trastuzumab and vinorelbine (HN) is a well-tolerated, active regimen for Her2 3+/FISH+stage II/III breast cancer

✍ Scribed by L.N. Harris; H. Burstein; R. Gelman; P. Freidman; I. Kuter; V. Borges; C. Kaelin; J. Bellon; D. Smith; E. Winer

• Book ID: 118620571
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 155 KB
• Volume: 1
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(03)90429-0